<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>101(36)</volume><submitter>Li J</submitter><pubmed_abstract>We evaluated the diagnostic performance of both gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (Gd-EOB-DTPA-MRI) and contrast-enhanced ultrasound (CEUS) for focal liver lesions, especially for the detection of small (&lt;2 cm) intrahepatic lesions. We retrospectively reviewed patients who underwent Gd-EOB-DTPA-MRI and CEUS before liver resection and compared Gd-EOB-DTPA-MRI and CEUS in the detection of focal liver lesions. A total of 216 patients were included, and 309 lesions were found. The sensitivity values of MRI and CEUS for the main lesion were both more than 95%, and the coincidence rates were both more than 80%. Regarding lesions &lt;2 cm, 135 such lesions were detected by MRI, whereas only 85 were detected by CEUS. For lesions &lt;2 cm, the sensitivity, specificity, and coincidence rates of MRI were significantly better than those of CEUS. Among 27 patients, 50 more lesions were detected by MRI than CEUS, 56% (28/50) of which were malignant. For the large lesion, the diagnostic performance is similar between Gd-EOB-DTPA-MRI and CEUS, and the sensitivity and coincidence rates of both methods are high. Gd-EOB-DTPA-MRI is likely to detect small (&lt;2 cm) focal intrahepatic lesions.</pubmed_abstract><journal>Medicine</journal><pagination>e30482</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10980474</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A comparative study of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound in the detection of intrahepatic lesion.</pubmed_title><pmcid>PMC10980474</pmcid><pubmed_authors>He S</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Ye X</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Yuan G</pubmed_authors></additional><is_claimable>false</is_claimable><name>A comparative study of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound in the detection of intrahepatic lesion.</name><description>We evaluated the diagnostic performance of both gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (Gd-EOB-DTPA-MRI) and contrast-enhanced ultrasound (CEUS) for focal liver lesions, especially for the detection of small (&lt;2 cm) intrahepatic lesions. We retrospectively reviewed patients who underwent Gd-EOB-DTPA-MRI and CEUS before liver resection and compared Gd-EOB-DTPA-MRI and CEUS in the detection of focal liver lesions. A total of 216 patients were included, and 309 lesions were found. The sensitivity values of MRI and CEUS for the main lesion were both more than 95%, and the coincidence rates were both more than 80%. Regarding lesions &lt;2 cm, 135 such lesions were detected by MRI, whereas only 85 were detected by CEUS. For lesions &lt;2 cm, the sensitivity, specificity, and coincidence rates of MRI were significantly better than those of CEUS. Among 27 patients, 50 more lesions were detected by MRI than CEUS, 56% (28/50) of which were malignant. For the large lesion, the diagnostic performance is similar between Gd-EOB-DTPA-MRI and CEUS, and the sensitivity and coincidence rates of both methods are high. Gd-EOB-DTPA-MRI is likely to detect small (&lt;2 cm) focal intrahepatic lesions.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-26T11:21:14.587Z</modification><creation>2025-04-06T13:41:00.572Z</creation></dates><accession>S-EPMC10980474</accession><cross_references><pubmed>36086711</pubmed><doi>10.1097/MD.0000000000030482</doi></cross_references></HashMap>